Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention
Amit N. Vora(Duke University), Sunil V. Rao(New York University), Manesh R. Patel(Duke University), Jeptha P. Curtis(Yale University), John C. Messenger(University of Colorado Anschutz Medical Campus), Matthew T. Roe(Clinical Research Institute), Hitinder S. Gurm(University of Michigan), Eric D. Peterson(The University of Texas Southwestern Medical Center), Laura Mauri(Brigham and Women's Hospital), Dadi Dai(University of Vermont), Amit P. Amin(Rush University Medical Center), Ehtisham Mahmud(Cardiovascular Institute of the South), Tracy Y. Wang(Clinical Research Institute), Harold L. Dauerman(University of Vermont Medical Center)
Cited by 44
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k